The AI Opportunity: Revolutionizing Clinical Trials, Transforming Healthcare
Special event at the 2025 BIO International Convention in Boston
Clinical Trials Ontario, Life Sciences Ontario, and OBIO® are bringing industry and research leaders together in Boston for an in-person event showcasing how artificial intelligence is transforming clinical trials and healthcare delivery.
Join the event on Monday, June 16, 2025, at the Westin Boston Seaport District for a morning of insights and networking as we explore how artificial intelligence is reshaping clinical trials and the broader healthcare landscape.
Key discussion areas include:
Impact of AI on clinical trials and data integration
Ontario and Canada’s advantages in conducting AI-driven research and innovation
Opportunities to enhance patient care and accelerate therapeutic development
Designed for leaders in the pharmaceutical and medical device industries, CROs, and business and healthcare innovators, this event highlights the strength of Canada’s research ecosystem and its role in advancing the future of global healthcare.
Meet the panelists:
Dr. Christine Allen, PhD
CEO of Intrepid Labs;
Co-Director of Acceleration Consortium at UofT
Anthony de Fazekas
Partner, IP at Mintz
Sebastien Latapie
Partner at Avant BIO
Dr. Fahad Razak, MD,
Provincial Clinical Lead at Ontario Health; Co-Lead at GEMINI;
Canada Research Chair in Data-Informed Healthcare Improvement at UofT
Lucas Siow
Co-founder & CEO of ProteinQure
The event is sponsored by:
